沈阳皮肤癣好的是那家医院沈阳头发少哪家医院治疗好,沈阳看头癣哪里比较好,沈阳皮肤癣检查费用多少,沈阳肤康治青春痘多少钱,沈阳皮肤过敏网上在线医院,沈阳市医院皮肤科看过疙瘩,哪里青春痘比较好沈阳市

President Donald Trump falsely claimed Saturday that the New York Stock Exchange re-opened the day after the September 11, 2001, terrorist attacks in an effort to justify holding a rally on the same day that a mass shooting occurred at a synagogue in Pittsburgh.Speaking at a planned campaign rally in Illinois, Trump said he had weighed whether to cancel his rally as well as a speech at an agricultural convention earlier in the day in Indianapolis, Indiana, but ultimately decided against it, saying such a move would amount to giving the killer an edge. He compared his decision to continue with the rally to reopening the NYSE after the September 11 attacks, something that did not happen."And with what happened early today -- that horrible, horrible attack in Pittsburgh -- I was saying maybe I should cancel both this and that," Trump said, referring to the rally and his earlier appearance at the agricultural convention. "And then I said to myself, I remember Dick Grasso, a friend of mine, great guy. He headed up the New York Stock Exchange on September 11. And the New York Stock Exchange was open the following day. He said -- and what they had to do to open it you wouldn't believe. We won't even talk to you about it. But he got that exchange open." 1273

President Donald Trump on multiple occasions raised with Deputy Attorney General Rod Rosenstein and Matt Whitaker, who was then-chief of staff to Jeff Sessions, whether the Justice Department was progressing in investigating Hillary Clinton, according to a source familiar with the matter.The President also wanted his previous White House counsel, Don McGahn, to ask the Justice Department to prosecute Clinton on numerous occasions, but McGahn rebuffed doing that, the source said.Anticipating the question about Clinton would be raised, Whitaker came prepared to answer with what Justice was doing on Clinton-related matters, including the Clinton Foundation and Uranium One investigations, the source said. The source added that Whitaker was trying to appease the President, but did not seem to cross any line.The New York Times first reported on Trump's requests to McGahn to prosecute Clinton, as well as former FBI Director James Comey.The Justice Department did not immediately respond to CNN's requests for comment.In March, then-Attorney General Sessions revealed that Utah's top federal prosecutor, John Huber, was looking into allegations that the FBI abused its powers in surveilling a former Trump campaign adviser, and claims that more should have been done to investigate Clinton's ties to a Russian nuclear energy agency, which have not been proven.And in January, CNN reported that the US attorney and FBI in Arkansas were investigating allegations of corruption related to the Clinton Foundation. The FBI and federal prosecutors are looking into whether donors to the foundation were improperly promised policy favors or special access to Clinton while she was secretary of state in exchange for donations to the charity's coffers, as well as whether tax-exempt funds were misused, the official said. A spokesman for Clinton dismissed the allegations as unfounded.William Burck, a lawyer for McGahn, issued a statement following the Times report that said the President hadn't ordered prosecutions of Clinton or Comey."Mr. McGahn will not comment on his legal advice to the president. Like any client, the president is entitled to confidentiality. Mr. McGahn would point out, though, that the president never, to his knowledge, ordered that anyone prosecute Hillary Clinton or James Comey," Burck said.The White House did not immediately respond to CNN's requests for comment.This is a breaking story and will be updated.The-CNN-Wire 2460

President Donald Trump on Friday responded to Jeff Sessions' defiance over the handling of the Justice Department by resuming his remarkable public hammering of the attorney general and suggesting Sessions pursue the White House's political opponents."Jeff, this is GREAT, what everyone wants, so look into all of the corruption on the "other side" including deleted Emails, Comey lies & leaks, Mueller conflicts, McCabe, Strzok, Page, Ohr...FISA abuse, Christopher Steele & his phony and corrupt Dossier, the Clinton Foundation, illegal surveillance of Trump Campaign, Russian collusion by Dems - and so much more. Open up the papers & documents without redaction? Come on Jeff, you can do it, the country is waiting!" Trump wrote on Twitter Friday morning. 778

President Donald Trump laid out his health care agenda Thursday amid a global pandemic and growing uncertainty about the future of the Affordable Care Act, the Obama-era law he vowed to replace with a much better plan, but never did. In a campaign-style visit to swing state North Carolina, the president sketched out what aides call a “vision” for quality health care at affordable prices, lower prescription drug costs and greater consumer choice. Although the Trump administration has made some progress on his health care goals, the major changes he promised have eluded him. And the clock has all but run out in Congress.Among one of the points highlighted in his executive order was his promise to make preexisting conditions covered by insurance companies. But this point is already covered by the Affordable Care Act, which the Trump administration is working to get overturned in the federal courts. 920

President Donald Trump once again promoted hydroxychloroquine as a COVID-19 treatment despite a number of trials disputing its efficacy.Questions on Trump’s support of the largely unproven drug comes as Trump retweeted a video that called the drug a “cure” for the coronavirus. Twitter, Facebook and YouTube have since pulled the video from their platforms.The video also caused Twitter to suspend the account of Trump’s son Donald Trump Jr.Major public health organizations have disputed the efficacy of the drug. Early results of the drug’s usage in peer reviewed trials have not been promising, according to the FDA. The FDA has banned the use of the drug to treat coronavirus outside of hospital and clinical trial settings. But Trump continues to place hopes in hydroxychloroquine.“I happen to believe in it. I would take it,” Trump said on Tuesday. “As you know, I took it for a 14-day period, and I'm here. Right? I'm here. I happen to think it's -- it works in the early stages.”Recently, the White House began promoting a study by the Henry Ford Health System, which did indicate that the drug reduced mortality. But a number of other studies have not been able to replicate Henry Ford Health System's findings. Most recently, the New England Journal of Medicine published last week a study that indicated that the drug did not improve coronavirus outcomes. But the FDA has said that the drug carries dangerous side effects, and several initial studies indicated that the drug is not an effective treatment for COVID-19. In June, the FDA withdrew an emergency use authorization of the drug. An EUA allowed doctors to use treatments by weighing potential benefits over potential risks.“We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery,” the FDA said. “This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19.”In April, the FDA first put out guidance that warned against the use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to possible side effects. The FDA added that hydroxychloroquine and chloroquine had not been shown to be safe and effective for treating or preventing COVID-19.The FDA said that hydroxychloroquine can cause abnormal heart rhythms, and patients who also have other health issues such as heart and kidney disease are likely to be at increased risk of complications.Hydroxychloroquine, a treatment that is commonly used to treat malaria and lupus, can be provided as a treatment for COVID-19 patients on an experimental basis. 2820